Decreased Skeletal Muscle Mitochondrial DNA in Patients Treated with High-Dose Simvastatin
- 28 February 2007
- journal article
- research article
- Published by Wiley in Cancer Cell
- Vol. 81 (5), 650-653
- https://doi.org/10.1038/sj.clpt.6100124
Abstract
Statins are generally well tolerated, but can cause myopathy 1 and have been associated with mitochondrial abnormalities. 2 , 3 , 4 , 5 , 6 The aim of this study was to determine whether muscle mitochondrial DNA (mtDNA) levels are altered during statin therapy. We retrospectively quantified mtDNA in 86 skeletal muscle biopsy specimens collected as part of a previously published 7 clinical trial of high‐dose simvastatin or atorvastatin versus placebo. Clinical Pharmacology & Therapeutics (2007) 81, 650–653. doi:10.1038/sj.clpt.6100124; published online 28 February 2007Keywords
This publication has 18 references indexed in Scilit:
- An Assessment of Statin Safety by Muscle ExpertsThe American Journal of Cardiology, 2006
- Considerations for Supplementing with Coenzyme Q10 During Statin TherapyAnnals of Pharmacotherapy, 2006
- Statin-related adverse events: A meta-analysisClinical Therapeutics, 2006
- Muscle Coenzyme Q10 Level in Statin-Related MyopathyArchives of Neurology, 2005
- High-dose statins and skeletal muscle metabolism in humans: A randomized, controlled trialCancer Cell, 2005
- Simvastatin triggers mitochondria-induced Ca2+ signaling alteration in skeletal muscleBiochemical and Biophysical Research Communications, 2005
- Statin-Associated Myopathy with Normal Creatine Kinase LevelsAnnals of Internal Medicine, 2002
- Mitochondrial DNA Depletion Syndrome is Expressed in Amniotic Fluid Cell CulturesThe American Journal of Pathology, 1999
- Comparative Dose Efficacy Study of Atorvastatin Versus Simvastatin, Pravastatin, Lovastatin, and Fluvastatin in Patients With Hypercholesterolemia (The CURVES Study) fn1fn1This study was supported by Parke-Davis, Division of Warner Lambert Company, Morris Plains, New Jersey. Manuscript received August 20, 1997; revised manuscript received and accepted November 24, 1997.The American Journal of Cardiology, 1998
- The rule of 5 and the rule of 7 in lipid-lowering by statin drugsThe American Journal of Cardiology, 1997